1.H. sinensis mycelium inhibits epithelial-mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis.
Li LU ; Haiyan ZHU ; Hailin WANG ; Huaping LIANG ; Yayi HOU ; Huan DOU
Frontiers of Medicine 2021;15(2):313-329
The medical fungus Hirsutella sinensis has been used as a Chinese folk health supplement because of its immunomodulatory properties. Our previous studies established the antifibrotic action of Hirsutella sinensis mycelium (HSM) in the lung. The epithelial-mesenchymal transition (EMT) is involved in the pathogenesis of idiopathic pulmonary fibrosis. The present study investigates the role of HSM in mediating EMT during the development of pulmonary fibrosis. HSM significantly inhibits bleomycin (BLM)-induced pulmonary fibrosis by blocking the EMT. In addition, the expression levels of midkine are increased in the lungs of the BLM-induced group. Further analysis of the results indicates that the mRNA level of midkine correlated positively with EMT. HSM markedly abrogates the transforming growth factor β-induced EMT-like phenotype and behavior in vitro. The activation of midkine related signaling pathway is ameliorated following HSM treatment, whereas this extract also caused an effective attenuation of the induction of EMT (caused by midkine overexpression) in vitro. Results further confirm that oral medication of HSM disrupted the midkine pathway in vivo. Overall, findings suggest that the midkine pathway and the regulation of the EMT may be considered novel candidate therapeutic targets for the antifibrotic effects caused by HSM.
Bleomycin
;
Epithelial-Mesenchymal Transition
;
Humans
;
Midkine
;
Mycelium
;
Pulmonary Fibrosis/drug therapy*
2.The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance.
Yuying LIU ; Xijun XUE ; Fang WANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2008;22(3):100-103
OBJECTIVE:
To explore the expressions of thymidine phosphorylase (TP), midkine (MK) and MVD marked with CD105 antibody in laryngeal squamous cell carcinoma (LSCC) and their clinical significance.
METHOD:
The expressions of TP, MK and CD105 in LSCC tissues of 43 cases were studied by immunohistochemical staining.
RESULT:
The positive expression rates of TP and MK in LSCC were 67.4% and 60.5% respectively, the mean value of MVD was 6.01 +/- 1.78. MVD was significantly higher in tumor tissue with both positive TP and MK than in that with both negative TP and MK (7.07 +/- 3.26 vs. 4.03 +/- 1.90, P < 0.05). The expression of TP, MK and CD105 were all correlated with T-stage and lymph node metastasis. Positive TP, MK expression and high MVD were all associated with a poor survival, and positive expression of both TP and MK in tumors conferred a poorer prognosis than negative expression of those factors in tumors, but only the lymph node metastasis and MVD were independent prognostic factors on multivariate analysis.
CONCLUSION
Both TP and MK are important for angiogenesis in LSCC. TP, MK and angiogenesis are all closely correlated with the progress of LSCC and the lymph node metastasis. The lymph node metastasis and MVD marked with CD105 antibody were independent prognostic factors. TP and MK may affect the progression and prognosis of tumor by promotion of angiogenesis. A combinative detection of TP, MK and CD105 can be as valuable tumor marker and prognostic factor for LSCC.
Adult
;
Aged
;
Antigens, CD
;
metabolism
;
Carcinoma, Squamous Cell
;
blood supply
;
metabolism
;
pathology
;
Endoglin
;
Female
;
Humans
;
Laryngeal Neoplasms
;
blood supply
;
metabolism
;
pathology
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Midkine
;
Neoplasm Staging
;
Neovascularization, Pathologic
;
Nerve Growth Factors
;
metabolism
;
Prognosis
;
Receptors, Cell Surface
;
metabolism
;
Thymidine Phosphorylase
;
metabolism